Accelerated Pharma (Accelerated Pharma) Dividends per Share : $0.00 (TTM As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Dividends per Share?

Accelerated Pharma's dividends per share for the three months ended in Mar. 2017 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2017 was $0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2017 was 0.00. As of today, Accelerated Pharma's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Accelerated Pharma Dividends per Share Historical Data

The historical data trend for Accelerated Pharma's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Dividends per Share Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dividends per Share

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Dividends per Share	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Accelerated Pharma's Dividends per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Accelerated Pharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accelerated Pharma's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Accelerated Pharma's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Accelerated Pharma's Dividend Yield % falls into.

Accelerated Pharma Dividends per Share Calculation

Dividends paid to per common share.

Accelerated Pharma (NAS:ACCP) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Accelerated Pharma's Dividend Payout Ratio for the quarter that ended in Mar. 2017 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2017 )	/	EPS without NRI (Q: Mar. 2017 )
	=	0	/	-0.09
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Accelerated Pharma Dividends per Share Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines